| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance
DOI: 10.1016/j.urolonc.2011.12.018
Abstract: Objective: To evaluate the impact of detailed biopsy characteristics such as positive cores location or multifocality on the risk of initial reclassification in prostate cancer (CaP) patient...
|
Guillaume Ploussard,
Alexandre de la Taille,
Stéphane Terry,
Yves Allory,
Idir Ouzaïd,
Francis Vacherot,
Claude-Clément Abbou,
Laurent Salomon
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 February 2012 |
|
Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma
DOI: 10.1016/j.urolonc.2011.12.021
Abstract: Objectives: To determine accuracy of upper tract cytology and ureteroscopic biopsy according to the 2004 World Health Organization (WHO) classification in predicting the correct tumor grade ...
|
Julia Straub,
Frank Strittmatter,
Alexander Karl,
Christian G. Stief,
Stefan Tritschler
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 February 2012 |
|
Summary of the 6th annual bladder cancer think tank: New directions in urologic research
DOI: 10.1016/j.urolonc.2011.12.017
Abstract: The 6th Annual Bladder Cancer Think Tank brought together a multidisciplinary group of clinicians, researchers, and representatives from the National Cancer Institute and Industry in an effo...
|
Robert S. Svatek,
Jonathan E. Rosenberg,
Matthew D. Galsky,
Cheryl T. Lee,
David M. Latini,
Bernard H. Bochner,
Alon Z. Weizer,
Andrea B. Apolo,
Srikala S. Sridhar,
Ashish M. Kamat,
Donna Hansel,
Thomas W. Flaig,
Norm D. Smith,
Yair Lotan
et al.
|
Review article
(In Press Corrected Proof)
|
02 February 2012 |
|
Fibroblast growth factor receptor-3 in urothelial tumorigenesis☆
DOI: 10.1016/j.urolonc.2011.12.001
Abstract: Fibroblast growth factor receptor-3 (FGFR3) is a receptor tyrosine kinase implicated in the tumorigenesis of multiple malignancies, including bladder and other urothelial cancers, multiple m...
|
Gopa Iyer,
Matthew I. Milowsky
|
Review article
(In Press Corrected Proof)
|
30 January 2012 |
|
Bacteriuria and antibiotic resistance in catheter urine specimens following radical prostatectomy1
DOI: 10.1016/j.urolonc.2011.12.008
Abstract: Objective: There are increasing reports of infectious complications following prostate biopsy due to fluoroquinolone resistance. To determine infectious complications at catheter removal fol...
|
Jessica A. Banks,
Barry B. McGuire,
Stacy Loeb,
Sanjina Shrestha,
Brian T. Helfand,
William J. Catalona
et al.
|
Full-length article
(In Press Corrected Proof)
|
30 January 2012 |
|
Capsular invasion in renal cell carcinoma: A meta-analysis
DOI: 10.1016/j.urolonc.2011.12.019
Abstract: Objectives: Capsular invasion is frequently detected in localized renal cell carcinoma (RCCs) samples. Whether patients with localized RCCs and capsular invasion will suffer poorer clinical ...
|
Turun Song,
Yuan Yin,
Banghua Liao,
Shuo Zheng,
Qiang Wei
et al.
|
Full-length article
(In Press Corrected Proof)
|
30 January 2012 |
|
Patients and partners lack knowledge of androgen deprivation therapy side effects
DOI: 10.1016/j.urolonc.2011.12.015
Abstract: Objective: Androgen deprivation therapy (ADT) is the primary treatment for advanced prostate cancer (CaP). There is growing evidence that ADT negatively affects men's psychosocial well-being...
|
Lauren M. Walker,
Susan Tran,
Richard J. Wassersug,
Bejoy Thomas,
John W. Robinson
et al.
|
Full-length article
(In Press Corrected Proof)
|
30 January 2012 |
|
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study
DOI: 10.1016/j.urolonc.2011.12.013
Abstract: Objectives: Type-2 diabetes mellitus (DM) is a metabolic disease affecting several million people all over the world. The correlation between DM and malignancies is well established due to t...
|
Alessandro Antonelli,
Nicola Arrighi,
Serena Corti,
Tiziano Zanotelli,
Alberto Cozzoli,
Sergio Cosciani Cunico,
Claudio Simeone
et al.
|
Full-length article
(In Press Corrected Proof)
|
27 January 2012 |
|
Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes
DOI: 10.1016/j.urolonc.2011.12.009
Abstract: The progressive increase in sporadic renal cell carcinoma (RCC) observed in industrialized countries supports the opinion that certain carcinogens present in the environment (tobacco smoke, ...
|
Shiekh Tanveer Ahmad,
Wani Arjumand,
Amlesh Seth,
Sana Nafees,
Summya Rashid,
Nemat Ali,
Oday O. Hamiza,
Sarwat Sultana
et al.
|
Full-length article
(In Press Corrected Proof)
|
27 January 2012 |
|
Patterns of autophagy in urothelial cell carcinomas—the significance of “stone-like” structures (SLS) in transurethral resection biopsies
DOI: 10.1016/j.urolonc.2011.12.016
Abstract: 0bjectives: To investigate the microtubule-associated protein LC3A, presumed to reflect autophagic activity, in urothelial cell carcinomas (UCC) for its relevance with muscle invasion in tra...
|
Efthimios Sivridis,
Michael I. Koukourakis,
Savvas E. Mendrinos,
Stavros Touloupidis,
Alexandra Giatromanolaki
et al.
|
Full-length article
(In Press Corrected Proof)
|
27 January 2012 |
|
The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor
DOI: 10.1016/j.urolonc.2011.11.030
Abstract: Objective: Emerging evidences implicate long noncoding RNAs (lncRNAs) are deregulated in cancer development. The purpose of the current study is to investigate the role of new lncRNA, named ...
|
Zilian Cui,
Shancheng Ren,
Ji Lu,
Fubo Wang,
Weidong Xu,
Yi Sun,
Min Wei,
Junyi Chen,
Xu Gao,
Chuanliang Xu,
Jian-Hua Mao,
Yinghao Sun
et al.
|
Full-length article
(In Press Corrected Proof)
|
24 January 2012 |
|
Adjuvant and neoadjuvant therapy for renal cell carcinoma: A survey of the Society of Urologic Oncology
DOI: 10.1016/j.urolonc.2011.12.014
Abstract: Objective: Several systemic agents have been approved for patients with advanced renal cell carcinoma (RCC) and others are in various stages of development. We surveyed members of the Societ...
|
Conrad M. Tobert,
Robert G. Uzzo,
Christopher G. Wood,
Brian R. Lane
|
Full-length article
(In Press Corrected Proof)
|
24 January 2012 |
|
Positive surgical margins at radical prostatectomy: Much ado about nothing?
DOI: 10.1016/j.urolonc.2011.12.005
“Medicine is a science of uncertainty and an art of probability.” -William Osler. The finding of positive surgical margins (PSM) following radical prostatectomy (RP) continues to induce angst amongst ...
|
Matthew J. Resnick,
Michael S. Cookson
|
News
(In Press Corrected Proof)
|
13 January 2012 |
|
Radical prostatectomy: Positive surgical margins matter
DOI: 10.1016/j.urolonc.2011.12.011
Abstract: Objective: A positive surgical margin (PSM) in the radical prostatectomy (RP) specimen is associated with biochemical recurrence (BCR) and the need for adjuvant radiation therapy, and is a s...
|
Joshua J. Meeks,
James A. Eastham
|
Review article
(In Press Corrected Proof)
|
13 January 2012 |
|
Natural history of untreated renal cell carcinoma with venous tumor thrombus
DOI: 10.1016/j.urolonc.2011.12.006
Abstract: Objectives: The natural history of untreated renal cell carcinoma (RCC) with venous tumor thrombus (VTT) is poorly characterized. We aimed to describe the natural history of this disease, an...
|
Adam C. Reese,
Jared M. Whitson,
Maxwell V. Meng
|
Full-length article
(In Press Corrected Proof)
|
12 January 2012 |
|
Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells
DOI: 10.1016/j.urolonc.2011.12.007
Abstract: Purpose: Tumor hypoxia is a common feature of any cancer, including prostate cancer (CaP), and associated with tumor cell aggressiveness. Although some reports are available on acute hypoxia...
|
Mutsushi Yamasaki,
Takeo Nomura,
Fuminori Sato,
Hiromitsu Mimata
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer
DOI: 10.1016/j.urolonc.2011.12.003
Abstract: Background and objective: Inhibitor of differentiation or DNA binding -1 (Id-1) has been shown to be increased in several types of advanced cancer, and to be associated with aggressive and m...
|
Hao Hu,
Yu Liang Wang,
Gong Wei Wang,
Yong Chuan Wong,
Xiao Feng Wang,
Ying Wang,
Ke Xin Xu
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Open vs. robotic-assisted radical prostatectomy: A single surgeon and pathologist comparison of pathologic and oncologic outcomes
DOI: 10.1016/j.urolonc.2011.12.002
Abstract: Objective: To compare the impact surgical technique has on clinicopathologic and oncologic outcomes among patients undergoing radical prostatectomy for clinically localized prostate cancer. ...
|
Timothy A. Masterson,
Liang Cheng,
Ronald S. Boris,
Michael O. Koch
|
Full-length article
(In Press Corrected Proof)
|
06 January 2012 |
|
Smaller prostate gland size and older age predict Gleason score upgrading
DOI: 10.1016/j.urolonc.2011.11.032
Abstract: Objectives: Gleason score is important for prostate cancer (CaP) risk stratification and prognostication but has a significant rate of upgrading. We examined the effect of prostate size and ...
|
Boris Gershman,
Douglas M. Dahl,
Aria F. Olumi,
Robert H. Young,
W. Scott McDougal,
Chin-Lee Wu
et al.
|
Full-length article
(In Press Corrected Proof)
|
30 December 2011 |
|
Bladder cancer: A window of opportunity to understand carcinogenesis
DOI: 10.1016/j.urolonc.2011.11.029
Abstract: Bladder cancer provides a unique opportunity to apply our knowledge of the molecular biology of the malignancy to its clinical behavior and prognosis. Urologists should apply the increasing ...
|
Kevin R. Loughlin
|
Review article
(In Press Corrected Proof)
|
26 December 2011 |
|
Measurement of PSA density by 3 imaging modalities and its correlation with the PSA density of radical prostatectomy specimen
DOI: 10.1016/j.urolonc.2011.11.033
Abstract: Objective: To evaluate the difference between the PSA density (PSAD) calculated with 3 imaging modalities and the PSAD of the radical prostatectomy specimen. Materials and methods: The PSAD ...
|
Ioannis Varkarakis,
Adam Zarkadoulias,
Andreas Bourdoumis,
Eleutherios Chatzidarellis,
Nikolaos Antoniou,
Charalambos Deliveliotis
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder
DOI: 10.1016/j.urolonc.2011.11.028
Abstract: Objectives: Polo-like kinase 1 (Plk1) has been widely pursued as an oncology target because it is overexpressed in several human tumor types. To investigate whether Plk1 plays a general role...
|
Zhe Zhang,
Guojun Zhang,
Chuize Kong
|
Full-length article
(In Press Corrected Proof)
|
22 December 2011 |
|
Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis
DOI: 10.1016/j.urolonc.2011.11.031
Abstract: Objectives: We have reported previously that the TP53 codon72 polymorphism (rs1042522) is associated with the incidence and invasiveness of bladder cancer in a Han Chinese population. Using ...
|
Hung-Yu Lin,
Ming-Chang Yang,
Chun-Hsiung Huang,
Wen-Jen Wu,
Tsan-Jung Yu,
For-Wey Lung
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 December 2011 |
|
Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility
DOI: 10.1016/j.urolonc.2011.11.027
Abstract: The glutathione-S-transferases (GSTs) comprise a class of enzymes that detoxify carcinogenic compounds by conjugating glutathione to facilitate their removal. Polymorphisms in GSTM1, GSTT1, ...
|
Mohammad Reza Safarinejad,
Saba Safarinejad,
Nayyer Shafiei,
Shiva Safarinejad
|
Full-length article
(In Press Corrected Proof)
|
12 December 2011 |
|
The surgical management and prognosis of renal cell cancer with IVC tumor thrombus: 15-Years of experience using a multi-specialty approach at a single UK referral center
DOI: 10.1016/j.urolonc.2011.11.001
Abstract: Objectives: Surgical management of renal cell carcinoma (RCC) invading the inferior vena cava (IVC) remains a technical challenge. However, radical surgery is the only potentially curative t...
|
Ased S.M. Ali,
Nikhil Vasdev,
Selvaraj Shanmuganathan,
Edgar Paez,
John H. Dark,
Derek Manas,
David J. Thomas
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 December 2011 |
|
In vivo and in vitro effects of RAD001 on bladder cancer
DOI: 10.1016/j.urolonc.2011.11.002
Abstract: Objective: To evaluate the influence of Everolimus (RAD001) on chemically induced urothelial lesions in mice and its influence on in vitro human bladder cancer cell lines. Methods: ICR male ...
|
Carmen Vasconcelos-Nóbrega,
Rosario Pinto-Leite,
Regina Arantes-Rodrigues,
Rita Ferreira,
Paulo Brochado,
Maria L. Cardoso,
Carlos Palmeira,
Alexandre Salvador,
Catarina I. Guedes-Teixeira,
Aura Colaço,
Luis F. Palomino,
Carlos Lopes,
Lúcio Santos,
Paula A. Oliveira
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 December 2011 |
|
Stress-activated kinase pathway alteration is a frequent event in bladder cancer
DOI: 10.1016/j.urolonc.2010.03.002
Abstract: Objectives: The stress-activated MAP kinases (SAPK) signaling pathways play a critical role in the cellular response to toxins and physical stress, mediate inflammation, and modulate carcino...
|
Kristen B. Otto,
Sujeet S. Acharya,
Victoria L. Robinson
|
Full-length article
(In Press Corrected Proof)
|
12 December 2011 |
|
The significant immunological characteristics of peripheral blood neutrophil-to-lymphocyte ratio and Fas ligand expression incidence in nephrectomized tumor in late recurrence from renal cell carcinoma
DOI: 10.1016/j.urolonc.2011.09.008
Abstract: Objective: In order to characterize the significance of immune system function in patients with advanced renal cell carcinoma (RCC), we investigated the interactive relationships among the f...
|
Takehiro Sejima,
Hideto Iwamoto,
Shuichi Morizane,
Nobuyuki Hinata,
Akihisa Yao,
Tadahiro Isoyama,
Motoaki Saito,
Atsushi Takenaka
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 December 2011 |
|
Consolidative surgery after targeted therapy for renal cell carcinoma
DOI: 10.1016/j.urolonc.2011.10.005
Abstract: Renal cell carcinoma is the most lethal of the common genitourinary neoplasms, with 30% to 40% of patients eventually dying from disease progression. Although the recent development of targe...
|
Anil A. Thomas,
Steven C. Campbell
|
Review article
(In Press Corrected Proof)
|
09 December 2011 |
|
The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi-center randomized trial
DOI: 10.1016/j.urolonc.2011.10.004
Abstract: Objective: The purpose of this trial was to compare usual patient education plus the Internet-based Personal Patient Profile-Prostate, vs. usual education alone, on conflict associated with ...
|
Donna L. Berry,
Barbara Halpenny,
Fangxin Hong,
Seth Wolpin,
William B. Lober,
Kenneth J. Russell,
William J. Ellis,
Usha Govindarajulu,
Jaclyn Bosco,
B. Joyce Davison,
Gerald Bennett,
Martha K. Terris,
Andrea Barsevick,
Daniel W. Lin,
Claire C. Yang,
Greg Swanson
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 December 2011 |
|
Orthotopic sigmoid vs. ileal neobladders in Japanese patients: A comparative assessment of complications, functional outcomes, and quality of life
DOI: 10.1016/j.urolonc.2011.11.015
Abstract: Objectives: To compare the clinical outcomes of sigmoid and ileal neobladders (NBs) created following radical cystectomy. Materials and methods: This study included 90 and 144 Japanese patie...
|
Hideaki Miyake,
Junya Furukawa,
Iori Sakai,
Mototsugu Muramaki,
Masuo Yamashita,
Taka-aki Inoue,
Masato Fujisawa
et al.
|
Full-length article
(In Press Corrected Proof)
|
08 December 2011 |
|
Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells
DOI: 10.1016/j.urolonc.2011.10.009
Abstract: Bladder cancer is the most prevalent tumor in the genitourinary tract and the current treatments are not efficient to prevent recurrence and progression of tumor cases. Studies have revealed...
|
Liliana Rockenbach,
Luci Bavaresco,
Patrícia Fernandes Farias,
Angélica Regina Cappellari,
Carlos Henrique Barrios,
Fernanda Bueno Morrone,
Ana Maria Oliveira Battastini
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 December 2011 |
|
Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma
DOI: 10.1016/j.urolonc.2011.10.011
Abstract: Objective: To evaluate the performance of urine cytology (CYT), the UroVysion test [(fluorescence-in-situ-hybridization (FISH)], the uCyt+-test, and the nuclear matrix protein 22 ELISA (NMP2...
|
Tilman Todenhöfer,
Joerg Hennenlotter,
Veronika Tews,
Georgios Gakis,
Stefan Aufderklamm,
Ursula Kuehs,
Arnulf Stenzl,
Christian Schwentner
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 December 2011 |
|
Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells
DOI: 10.1016/j.urolonc.2011.10.008
Abstract: Background: Tumor hypoxia is a common feature of prostate tumors associated with the stabilization of hypoxia-inducible-factor 1alpha (HIF-1α) and poor prognosis following radiation therapy....
|
Derek Hennessey,
Lynn M. Martin,
Anne Atzberger,
Thomas H. Lynch,
Donal Hollywood,
Laure Marignol
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 December 2011 |
|
Early incontinence after radical prostatectomy: A community based retrospective analysis in 911 men and implications for preoperative counseling
DOI: 10.1016/j.urolonc.2011.10.003
Abstract: Introduction: Radical prostatectomy (RP) is curative for localized prostatic cancer. Incontinence after RP (P-RP-I) varies widely (2% to <60%) according to the definition and quantificati...
|
Wael Y. Khoder,
Matthias Trottmann,
Andrea Stuber,
Christian G. Stief,
Armin J. Becker
et al.
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
Discharge patterns after radical prostatectomy in the United States of America
DOI: 10.1016/j.urolonc.2011.10.007
Abstract: Objective: Discharge patterns, including prolonged length of stay (LOS) and adverse discharge disposition (ADD), are important clinical indicators of quality of care. We examined the effect ...
|
Quoc-Dien Trinh,
Marco Bianchi,
Maxine Sun,
Jesse Sammon,
Jan Schmitges,
Shahrokh F. Shariat,
Shyam Sukumar,
Claudio Jeldres,
Kevin Zorn,
Paul Perrotte,
Craig G. Rogers,
James O. Peabody,
Francesco Montorsi,
Mani Menon,
Pierre I. Karakiewicz
et al.
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
Adult urologic sarcoma: Experience during 2 decades
DOI: 10.1016/j.urolonc.2011.10.002
Abstract: Objective: To identify factors associated with long-term outcome and to report possibly meaningful clinical features in a unicentric sample of adult urologic sarcomas. Materials and methods:...
|
Michael Froehner,
Rebecca R. Schober,
Rainer Koch,
Arndt Lossnitzer,
Michael Laniado,
Manfred P. Wirth
et al.
|
Full-length article
(In Press Corrected Proof)
|
18 November 2011 |
|
Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder
DOI: 10.1016/j.urolonc.2011.02.009
Abstract: Objectives: To investigate the value of narrow-band imaging (NBI) flexible cystoscopy in the detection of urothelial carcinoma (UC) of the bladder. Materials and methods: Clinical data of 17...
|
Guangfu Chen,
Baojun Wang,
Hongzhao Li,
Xin Ma,
Taoping Shi,
Xu Zhang
et al.
|
Full-length article
(In Press Corrected Proof)
|
14 November 2011 |
|
Comprehensive handbook for developing a bladder cancer cystectomy database
DOI: 10.1016/j.urolonc.2011.09.004
Abstract: Objective: In an effort to standardize data collection for research regarding bladder cancer, the Bladder Cancer Working Group sought to provide a handbook that can be used as a guide for pr...
|
Yair Lotan,
Gilad Amiel,
Stephen A. Boorjian,
Peter E. Clark,
Michael Droller,
Jeffrey R. Gingrich,
Thomas J. Guzzo,
Brant A. Inman,
Ashish M. Kamat,
Larry Karsh,
Matthew E. Nielsen,
Norm D. Smith,
Shahrokh F. Shariat,
Robert S. Svatek,
Jennifer M. Taylor,
on Behalf of the Bladder Cancer Think Tank, and Bladder Cancer Advocacy Network
et al.
|
Review article
(In Press Corrected Proof)
|
07 November 2011 |
|
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a
DOI: 10.1016/j.urolonc.2011.09.011
Abstract: Background: Bladder cancer (UCB) staged pT4a show heterogeneous outcome after radical cystectomy (RC). No risk model has been established to date. Despite gender-specific differences, no com...
|
Matthias May,
Patrick J. Bastian,
Sabine Brookman-May,
Hans-Martin Fritsche,
Derya Tilki,
Wolfgang Otto,
Christian Bolenz,
Christian Gilfrich,
Lutz Trojan,
Edwin Herrmann,
Rudolf Moritz,
Arne Tiemann,
Stefan C. Müller,
Jörg Ellinger,
Alexander Buchner,
Christian G. Stief,
Wolf F. Wieland,
Thomas Höfner,
Markus Hohenfellner,
Axel Haferkamp,
Jan Roigas,
Mario Zacharias,
Philipp Nuhn,
Maximilian Burger
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 November 2011 |
|
Intravenous therapies for castration-resistant prostate cancer: Toxicities and adverse events
DOI: 10.1016/j.urolonc.2011.09.003
Abstract: Prostate cancer (CaP) continues to be a significant burden on men's health. While significant advances have been made in the diagnosis and treatment of localized disease, androgen deprivatio...
|
Eric A. Singer,
Ramaprasad Srinivasan
|
Review article
(In Press Corrected Proof)
|
20 October 2011 |
|
NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma
DOI: 10.1016/j.urolonc.2011.07.006
Abstract: Objectives: Although NOTCH1 plays a wide-ranging role in controlling cell fate, differentiation, and development, its pathologic roles in clear cell renal cell carcinoma (CCRCC) are still un...
|
Shangwen Liu,
Xin Ma,
Qing Ai,
Qingbo Huang,
Taoping Shi,
Mingyang Zhu,
Baojun Wang,
Xu Zhang
et al.
|
Full-length article
(In Press Corrected Proof)
|
13 October 2011 |
|
Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses⁎
DOI: 10.1016/j.urolonc.2011.09.002
Abstract: Objective: Novel strategies for the treatment of advanced prostate cancer (CaP), including immunotherapy or gene therapy, are currently under evaluation with Sipuleucel-T as first FDA-approv...
|
Tobias Maurer,
Christos Pournaras,
Juan A. Aguilar-Pimentel,
Mark Thalgott,
Thomas Horn,
Matthias Heck,
Antje Heit,
Hubert Kuebler,
Jürgen E. Gschwend,
Roman Nawroth
et al.
|
Full-length article
(In Press Corrected Proof)
|
10 October 2011 |
|
Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: Correlation with pathologic parameters and clinical outcome
DOI: 10.1016/j.urolonc.2011.08.006
Abstract: Objectives: To evaluate the role of lymph vessel density (LVD) and lymphangiogenesis in seminomatous testicular cancer (STC) by using the lymphatic endothelial cell (LEC) markers LYVE-1 and ...
|
Julia Heinzelbecker,
Kai-Michael Kempf,
Katrin Kurz,
Annette Steidler,
Christel Weiss,
David G. Jackson,
Christian Bolenz,
Axel Haecker,
Lutz Trojan
et al.
|
Full-length article
(In Press Corrected Proof)
|
05 October 2011 |
|
Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC)
DOI: 10.1016/j.urolonc.2011.08.012
Abstract: Objectives: To investigate the most recurrent deletion loci on 3p12-p26 by deletion mapping studies by PCR-LOH and BAC array-FISH in sporadic conventional renal cell carcinoma (cRCC) and fur...
|
Rashmi Bhat Singh,
Pratibha S. Amare Kadam
|
Full-length article
(In Press Corrected Proof)
|
03 October 2011 |
|
Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: A preliminary analysis
DOI: 10.1016/j.urolonc.2011.08.010
Abstract: Objective: Because of varying treatment effectiveness with vascular endothelial growth factor (VEGF)-targeted therapy in patients with metastatic renal cell carcinoma (RCC), the association ...
|
Andrew D. Smith,
Shetal N. Shah,
Brian I. Rini,
Michael L. Lieber,
Erick M. Remer
et al.
|
Full-length article
(In Press Corrected Proof)
|
28 September 2011 |
|
Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?
DOI: 10.1016/j.urolonc.2011.08.009
Abstract: Objectives: We investigated the prognosis of Japanese patients with metastatic renal cell carcinoma (RCC), and analyzed the validity of Memorial Sloan-Kettering Cancer Center (MSKCC) risk cl...
|
Nobuo Shinohara,
Takashige Abe,
Tango Mochizuki,
Akira Kashiwagi,
Kouichi Kanagawa,
Satoru Maruyama,
Ataru Sazawa,
Koji Oba,
Katsuya Nonomura
et al.
|
Full-length article
(In Press Corrected Proof)
|
28 September 2011 |
|
Is the diagnostic yield of prostate needle biopsies affected by prostate volume?
DOI: 10.1016/j.urolonc.2011.08.008
Abstract: Objectives: To determine the effect of prostate volume on the diagnostic yield of prostate biopsies. Materials and methods: 155 consecutive patients underwent 12-core transrectal ultrasound ...
|
Dan Leibovici,
Yaniv Shilo,
Orit Raz,
Kobi Stav,
Judith Sandbank,
Michael Segal,
Amnon Zisman
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 September 2011 |
|
When urothelial differentiation pathways go wrong: Implications for bladder cancer development and progression
DOI: 10.1016/j.urolonc.2011.07.017
Abstract: Differentiation is defined as the ability of a cell to acquire full functional behavior. For instance, the function of bladder urothelium is to act as a barrier to the diffusion of solutes i...
|
David J. DeGraff,
Justin M. Cates,
Joshua R. Mauney,
Peter E. Clark,
Robert J. Matusik,
Rosalyn M. Adam
et al.
|
Review article
(In Press Corrected Proof)
|
19 September 2011 |
|
Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study
DOI: 10.1016/j.urolonc.2011.08.007
Abstract: Objective: To evaluate the association between abdominal obesity and prostate cancer (CaP) diagnosis and grade in patients undergoing prostate biopsy. Materials and methods: Between 2008 and...
|
Cosimo De Nunzio,
Simone Albisinni,
Stephen J. Freedland,
Lucio Miano,
Luca Cindolo,
Enrico Finazzi Agrò,
Riccardo Autorino,
Marco De Sio,
Luigi Schips,
Andrea Tubaro
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 September 2011 |
|
Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer
DOI: 10.1016/j.urolonc.2011.08.001
Abstract: Objectives: Many strategies are pursued to enhance tumor vaccine immune response, including the utilization of cytokines. We have developed a novel protein-anchor technology to immobilize cy...
|
Xiaojun Shi,
Xinji Zhang,
Jinlong Li,
Fangfang Guo,
Zhiming Hu,
Yuming Jing,
Li Bai,
Sansan Chen,
Pei Wan,
Fei Wang,
Jimin Gao,
Wanlong Tan
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 September 2011 |
|
Should the presence of a culture positive urinary tract infection exclude patients from rapid evaluation hematuria protocols?
DOI: 10.1016/j.urolonc.2011.07.016
Abstract: Objective: Current rapid evaluation protocols for patients with hematuria tend to exclude those with urinary tract infection since this is assumed to be evidence of a benign treatable cause....
|
Nikhil Vasdev,
Andrew C. Thorpe
|
Full-length article
(In Press Corrected Proof)
|
14 September 2011 |
|
Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma
DOI: 10.1016/j.urolonc.2011.07.011
Abstract: Objective: The presence of hydronephrosis (HN) has been implicated as a predictor of poor outcomes for patients diagnosed with bladder cancer. Small, single institution preliminary reports s...
|
Jamie C. Messer,
John D. Terrell,
Michael P. Herman,
Casey K. Ng,
Douglas S. Scherr,
Benjamin Scoll,
Stephen A. Boorjian,
Robert G. Uzzo,
Mark Wille,
Scott E. Eggener,
Steven M. Lucas,
Yair Lotan,
Shahrokh F. Shariat,
Jay D. Raman
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 September 2011 |
|
The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer
DOI: 10.1016/j.urolonc.2011.07.012
Abstract: Objectives: The relationship between perioperative blood transfusion (PBT) and oncologic outcomes is controversial. In patients undergoing surgery for colon cancer and several other solid ma...
|
Todd M. Morgan,
Daniel A. Barocas,
Sam S. Chang,
Sharon E. Phillips,
Shady Salem,
Peter E. Clark,
David F. Penson,
Joseph A. Smith,
Michael S. Cookson
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 September 2011 |
|
Fine-tuning robot-assisted radical prostatectomy planning with MRI
DOI: 10.1016/j.urolonc.2011.07.013
Abstract: Objectives: Robot-assisted radical prostatectomy (RARP) has now become the most common surgical treatment option for prostate cancer (CaP). Clinicopathologic data (i.e., biopsy, digital rect...
|
David S. Finley,
Daniel Margolis,
Steve S. Raman,
Benjamin M. Ellingson,
Shyam Natarajan,
Nelly Tan,
Jiaoti Huang,
Robert E. Reiter
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 September 2011 |
|
Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis
DOI: 10.1016/j.urolonc.2011.07.009
Abstract: Objectives: High-grade T1 (HGT1) bladder cancer represents a heterogeneous disease with an aggressive phenotype. Despite prior reports demonstrating improved cancer-specific mortality (CSM) ...
|
Daniel Canter,
Brian Egleston,
Yu-Ning Wong,
Marc C. Smaldone,
Jay Simhan,
Richard E. Greenberg,
Robert G. Uzzo,
Alexander Kutikov
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 September 2011 |
|
A prospective comparison of the pathologic and surgical outcomes obtained after elective treatment of renal cell carcinoma by open or robot-assisted partial nephrectomy
DOI: 10.1016/j.urolonc.2011.08.004
Abstract: Objective: To prospectively compare surgical and pathologic outcomes obtained by elective robot-assisted (RAPN) or open partial nephrectomy (OPN) for small renal cell carcinoma (RCC). Materi...
|
Alexandra Masson-Lecomte,
David R. Yates,
Vincent Hupertan,
Alain Haertig,
Emmanuel Chartier-Kastler,
Marc-Olivier Bitker,
Christophe Vaessen,
Morgan Rouprêt
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 September 2011 |
|
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection
DOI: 10.1016/j.urolonc.2011.07.010
Abstract: Background: The use of magnetic resonance spectroscopy imaging (MRSI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) have emerged as a valid diagnostic tools for prostate...
|
Sisto Perdonà,
Giuseppe Di Lorenzo,
Riccardo Autorino,
Carlo Buonerba,
Marco De Sio,
Sergio Venanzio Setola,
Roberta Fusco,
Francesco Michele Ronza,
Michele Caraglia,
Matteo Ferro,
Antonella Petrillo
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 September 2011 |
|
A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder
DOI: 10.1016/j.urolonc.2011.07.015
Abstract: Background and objectives: Cisplatin-based chemotherapy is standard care for metastatic transitional cell carcinoma (TCC) of the urinary tract. However it is not appropriate for all patients...
|
Madhumita Bhattacharyya,
Tom Powles,
Katherine Mutsvangwa,
Peter Wilson,
Timothy Oliver,
Jonathan Shamash
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 September 2011 |
|
Small interfering RNA targeting heat shock protein 70 enhances chemosensitivity in human bladder cancer cells
DOI: 10.1016/j.urolonc.2011.07.007
Abstract: Objectives: To evaluate the expression levels of heat shock protein 70 (HSP70) in human urothelial cancer of the bladder and to assess the therapeutic effects of treatment with small interfe...
|
Hosny M. Behnsawy,
Hideaki Miyake,
Yuji Kusuda,
Masato Fujisawa
|
Full-length article
(In Press Corrected Proof)
|
05 September 2011 |